Kevin Outterson @koutterson.bsky.social · 01/12/2024But when data demonstrates a large mortality benefit in a low-income country (Niger) from mass administration of azithromycin to children under 5, some barriers are raised based on the impact on future resistance. 100
Kevin Outterson @koutterson.bsky.social · 01/12/2024The ethical imperative is to save lives now, with these decisions left in the hands of those most directly at risk. Our letter (with Maple Goh & Aaron Kesselheim) published in NEJM www.nejm.org/doi/full/10....nejm.orgAzithromycin to Reduce Mortality | NEJMTo the Editor: The AVENIR (Azithromycine pour la Vie des Enfants au Niger: Implementation et Recherche) trial reported by O’Brien et al. (Aug. 22/29 issue)1 shows the mortality benefit of mass dist... 000
